300254 仟源医药
已收盘 03-10 15:00:00
资讯
新帖
简况
股市必读:仟源医药(300254)3月4日董秘有最新回复
证券之星 · 03-05
股市必读:仟源医药(300254)3月4日董秘有最新回复
仟源医药:公司股东户数会随定期报告进行披露
证券日报网 · 03-04
仟源医药:公司股东户数会随定期报告进行披露
仟源医药(300254)披露持股5%以上第一大股东股份解除司法冻结公告,2月26日股价下跌2.25%
证券之星 · 02-26
仟源医药(300254)披露持股5%以上第一大股东股份解除司法冻结公告,2月26日股价下跌2.25%
仟源医药(300254)披露关于竞拍取得子公司少数股权的公告,2月25日股价上涨2.89%
证券之星 · 02-25
仟源医药(300254)披露关于竞拍取得子公司少数股权的公告,2月25日股价上涨2.89%
仟源医药(300254.SZ)竞得仟源海力生20%股权
智通财经 · 02-25
仟源医药(300254.SZ)竞得仟源海力生20%股权
2月24日仟源医药发布公告,股东减持353.53万股
证券之星 · 02-24
2月24日仟源医药发布公告,股东减持353.53万股
仟源医药(300254)披露2026年第一次临时股东会决议公告,1月30日股价上涨0.86%
证券之星 · 01-30
仟源医药(300254)披露2026年第一次临时股东会决议公告,1月30日股价上涨0.86%
仟源医药(300254)披露召开2026年第一次临时股东大会公告,1月27日股价下跌3.75%
证券之星 · 01-27
仟源医药(300254)披露召开2026年第一次临时股东大会公告,1月27日股价下跌3.75%
仟源医药(300254)披露拟回购注销部分限制性股票,1月13日股价上涨9.52%
证券之星 · 01-13
仟源医药(300254)披露拟回购注销部分限制性股票,1月13日股价上涨9.52%
仟源医药最新公告:子公司获得药品注册证书及化学原料药上市申请批准通知书
证券之星 · 01-05
仟源医药最新公告:子公司获得药品注册证书及化学原料药上市申请批准通知书
每周股票复盘:仟源医药(300254)董事高管减持计划实施完毕
证券之星 · 01-03
每周股票复盘:仟源医药(300254)董事高管减持计划实施完毕
11月24日仟源医药发布公告,股东减持119.71万股
证券之星 · 2025-11-24
11月24日仟源医药发布公告,股东减持119.71万股
11月21日仟源医药现1笔折价15.19%的大宗交易 合计成交825.89万元
证券之星 · 2025-11-21
11月21日仟源医药现1笔折价15.19%的大宗交易 合计成交825.89万元
11月19日仟源医药现1笔折价17.32%的大宗交易 合计成交902万元
证券之星 · 2025-11-19
11月19日仟源医药现1笔折价17.32%的大宗交易 合计成交902万元
股市必读:仟源医药(300254)11月12日董秘有最新回复
证券之星 · 2025-11-13
股市必读:仟源医药(300254)11月12日董秘有最新回复
仟源医药:生产盐酸氨溴索分散片等呼吸系统药物
证券之星 · 2025-11-12
仟源医药:生产盐酸氨溴索分散片等呼吸系统药物
图解仟源医药三季报:第三季度单季净利润同比增长106.06%
证券之星 · 2025-10-30
图解仟源医药三季报:第三季度单季净利润同比增长106.06%
仟源医药:10月28日高管虞英民减持股份合计10000股
证券之星 · 2025-10-29
仟源医药:10月28日高管虞英民减持股份合计10000股
仟源医药最新公告:股东翁占国拟减持不超3%公司股份
证券之星 · 2025-10-22
仟源医药最新公告:股东翁占国拟减持不超3%公司股份
10月22日仟源医药现492.3万元大宗交易
证券之星 · 2025-10-22
10月22日仟源医药现492.3万元大宗交易
加载更多
公司概况
公司名称:
山西仟源医药集团股份有限公司
所属行业:
医药制造业
上市日期:
2011-08-19
主营业务:
山西仟源医药集团股份有限公司的主营业务是医药、保健食品的研发、生产、销售及医学诊断、基因保存、孕环境检测。公司的主要产品是磷霉素氨丁三醇散、依巴斯汀片、盐酸坦索罗辛缓释胶囊、酒石酸伐尼克兰片、蒙脱石散、维生素AD滴剂、盐酸氨溴索分散片、盐酸舍曲林片、盐酸氟西汀胶囊、盐酸西那卡塞片、阿哌沙班片、利伐沙班片、精氨酸培哚普利片、保灵牌孕宝口服液、DNA基因保存。
发行价格:
13.00
{"stockData":{"symbol":"300254","market":"SZ","secType":"STK","nameCN":"仟源医药","latestPrice":12.55,"timestamp":1773126192000,"preClose":12.17,"halted":0,"volume":11103100,"delay":0,"changeRate":0.0312,"floatShares":225999999,"shares":256000000,"eps":0.0796,"marketStatus":"已收盘","change":0.38,"latestTime":"03-10 15:00:00","open":12.24,"high":12.69,"low":12.2,"amount":139000000,"amplitude":0.0403,"askPrice":12.56,"askSize":181,"bidPrice":12.55,"bidSize":25,"shortable":0,"etf":0,"ttmEps":0.0796,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773192600000},"marketStatusCode":5,"adr":0,"adjPreClose":12.17,"symbolType":"stock","openAndCloseTimeList":[[1773106200000,1773113400000],[1773118800000,1773126000000]],"highLimit":13.39,"lowLimit":10.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":256108563,"isCdr":false,"pbRate":10.59,"roa":"--","peRate":157.663317,"roe":"8.1%","epsLYR":0.1746,"committee":-0.496084,"marketValue":3214000000,"turnoverRate":0.0491,"status":0,"floatMarketCap":2835000000},"requestUrl":"/m/hq/s/300254","defaultTab":"news","newsList":[{"id":"2617550681","title":"股市必读:仟源医药(300254)3月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2617550681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617550681?lang=zh_cn&edition=full","pubTime":"2026-03-05 01:32","pubTimestamp":1772645532,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘,仟源医药报收于11.95元,下跌0.67%,换手率6.32%,成交量14.29万手,成交额1.72亿元。董秘最新回复投资者: 董秘您好,公司最近股东人数是多少?公司股东户数会随定期报告进行披露,对于其他时点的股东户数,如需查阅,请致电公司0352-6116426,公司核实您的股东身份后,将及时回复,感谢您的关注。当日关注点来自交易信息汇总:3月4日主力资金净流出768.28万元,散户资金净流入1321.27万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500000822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300254","BK0028","BK0114","BK0239","BK0077","BK0042","BK0046"],"gpt_icon":0},{"id":"2616326945","title":"仟源医药:公司股东户数会随定期报告进行披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326945","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326945?lang=zh_cn&edition=full","pubTime":"2026-03-04 19:38","pubTimestamp":1772624280,"startTime":"0","endTime":"0","summary":"证券日报网讯3月4日,仟源医药在互动平台回答投资者提问时表示,公司股东户数会随定期报告进行披露,对于其他时点的股东户数,如需查阅,请致电公司0352-6116426,公司核实股东身份后,将及时回复。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-04/doc-inhpvpqk3882576.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-04/doc-inhpvpqk3882576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","BK0046","BK0114","BK0042","BK0239","BK0028","300254"],"gpt_icon":0},{"id":"2614425028","title":"仟源医药(300254)披露持股5%以上第一大股东股份解除司法冻结公告,2月26日股价下跌2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614425028","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614425028?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:30","pubTimestamp":1772116243,"startTime":"0","endTime":"0","summary":"仟源医药于2026年2月26日发布公告称,公司持股5%以上第一大股东赵群先生所持有的公司股份已全部解除司法冻结。本次解除冻结股份总数为15,781,792股,占其所持股份比例的100%,占公司总股本的6.16%。冻结起始日为2026年2月6日,解除冻结日期为2026年2月24日,冻结法院为河北省石家庄市新华区人民法院。截至公告披露日,赵群先生所持本公司股份不存在被冻结情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0239","BK0046","BK0077","BK0042","BK0028","300254"],"gpt_icon":0},{"id":"2614333070","title":"仟源医药(300254)披露关于竞拍取得子公司少数股权的公告,2月25日股价上涨2.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614333070","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614333070?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:14","pubTimestamp":1772028862,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,仟源医药报收于12.46元,较前一交易日上涨2.89%,最新总市值为31.91亿元。该股当日开盘12.11元,最高12.59元,最低11.91元,成交额达2.27亿元,换手率为8.11%。仟源医药于2026年2月25日发布《关于竞拍取得子公司少数股权的公告》。2026年2月25日,公司与舟山荣豪以合计15,472万元竞得该股权,其中公司竞得20%股权,交易金额为7,736万元。交易完成后,公司持有仟源海力生股权由60%增至80%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500037960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0046","BK0042","300254","BK0028","BK0077","BK0239"],"gpt_icon":0},{"id":"2614835760","title":"仟源医药(300254.SZ)竞得仟源海力生20%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2614835760","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614835760?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:48","pubTimestamp":1772016539,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仟源医药(300254.SZ)公告,公司董事会授权经营层以自有资金与舟山荣豪贸易有限公司(简称“舟山荣豪”)联合参与海力生集团有限公司所持有浙江仟源海力生制药有限公司(简称“仟源海力生”)40%股权司法拍卖,公司与舟山荣豪各竞拍20%仟源海力生股权。于2026年2月25日,根据浙江省宁波市鄞州区人民法院淘宝网司法拍卖网络平台的公告信息,公司与舟山荣豪联合以1.55亿元价格竞得仟源海力生40%股权,公司持有仟源海力生股权将增加至80%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"仟源医药(300254.SZ)竞得仟源海力生20%股权","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0042","BK0077","BK0239","300254","BK0028","BK0114"],"gpt_icon":0},{"id":"2613790484","title":"2月24日仟源医药发布公告,股东减持353.53万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613790484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613790484?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:01","pubTimestamp":1771930879,"startTime":"0","endTime":"0","summary":"证券之星消息,2月24日仟源医药发布公告《仟源医药:关于持股5%以上股东减持股份实施情况暨减持完毕的公告》,其股东翁占国于2025年11月22日至2025年11月26日间合计减持353.53万股,占公司目前总股本的1.3804%,变动期间该股股价上涨4.67%,截止11月26日收盘报10.54元。股东增减持详情见下表:根据仟源医药2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","BK0046","BK0077","BK0028","BK0114","300254"],"gpt_icon":0},{"id":"2607130290","title":"仟源医药(300254)披露2026年第一次临时股东会决议公告,1月30日股价上涨0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607130290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607130290?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:30","pubTimestamp":1769765449,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,仟源医药报收于10.52元,较前一交易日上涨0.86%,最新总市值为26.94亿元。该股当日开盘10.37元,最高10.62元,最低10.36元,成交额达7070.89万元,换手率为2.98%。公司于近日披露《2026年第一次临时股东会决议公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000030751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0046","BK0077","300254","BK0239","BK0114"],"gpt_icon":0},{"id":"2606673822","title":"仟源医药(300254)披露召开2026年第一次临时股东大会公告,1月27日股价下跌3.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606673822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606673822?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:47","pubTimestamp":1769525232,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘,仟源医药报收于10.78元,较前一交易日下跌3.75%,最新总市值为27.61亿元。公司于近日披露《关于召开2026年第一次临时股东会的提示性公告》。公告显示,山西仟源医药集团股份有限公司将于2026年1月29日召开2026年第一次临时股东会,会议采取现场表决与网络投票相结合的方式。股权登记日为2026年1月22日,股东可在规定时间内通过现场或网络方式进行投票。中小投资者表决结果将单独计票并披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700042248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0114","BK0239","BK0046","300254","BK0042"],"gpt_icon":0},{"id":"2603680557","title":"仟源医药(300254)披露拟回购注销部分限制性股票,1月13日股价上涨9.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603680557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603680557?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:10","pubTimestamp":1768313428,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘,仟源医药报收于11.97元,较前一交易日上涨9.52%,最新总市值为30.66亿元。该股当日开盘11.02元,最高12.78元,最低10.94元,成交额达6.17亿元,换手率为23.16%。近日,仟源医药发布关于回购注销2025年限制性股票激励计划部分限制性股票的公告。公告称,公司于2026年1月13日召开第五届董事会第三十六次会议,审议通过相关议案。本次回购注销不影响公司正常财务状况及经营成果,公司股权分布仍具备上市条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300042114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0114","BK0042","BK0239","BK0046","BK0028","300254"],"gpt_icon":0},{"id":"2601883302","title":"仟源医药最新公告:子公司获得药品注册证书及化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2601883302","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601883302?lang=zh_cn&edition=full","pubTime":"2026-01-05 19:10","pubTimestamp":1767611423,"startTime":"0","endTime":"0","summary":"仟源医药(300254.SZ)公告称,子公司杭州仟源保灵药业有限公司收到国家药品监督管理局签发的依伏卡塞片《药品注册证书》,子公司江苏嘉逸医药有限公司收到依伏卡塞《化学原料药上市申请批准通知书》。依伏卡塞片适用于治疗维持性透析患者的继发性甲状旁腺功能亢进症,属于国家医保目录乙类品种。该药品的获批将丰富公司产品结构,提升市场竞争力,但未来销售情况存在不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500032528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0046","BK0077","300254","BK0239","BK0114"],"gpt_icon":0},{"id":"2600912060","title":"每周股票复盘:仟源医药(300254)董事高管减持计划实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2600912060","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600912060?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:47","pubTimestamp":1767383230,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,仟源医药报收于10.12元,较上周的10.13元下跌0.1%。本周,仟源医药12月30日盘中最高价报10.63元。12月31日盘中最低价报10.05元。仟源医药当前最新总市值25.92亿元,在化学制药板块市值排名141/150,在两市A股市值排名4810/5181。本次减持计划期限届满并实施完毕。减持行为符合相关法律法规规定,未导致公司控制权变更,不影响公司治理结构和经营。股份来源分别为首次公开发行前股份、股权激励授予及非公开发行股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0114","BK0042","300254","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2585184461","title":"11月24日仟源医药发布公告,股东减持119.71万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585184461","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585184461?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:01","pubTimestamp":1763985674,"startTime":"0","endTime":"0","summary":"证券之星消息,11月24日仟源医药发布公告《仟源医药:简式权益变动报告书》,其股东翁占国于2025年11月20日至2025年11月21日间合计减持119.71万股,占公司目前总股本的0.4674%,变动期间该股股价下跌7.7%,截止11月21日收盘报10.07元。股东增减持详情见下表:根据仟源医药2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400030276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300254","BK0046","BK0077","BK0239","BK0042","BK0028"],"gpt_icon":0},{"id":"2585118471","title":"11月21日仟源医药现1笔折价15.19%的大宗交易 合计成交825.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118471","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585118471?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:11","pubTimestamp":1763719870,"startTime":"0","endTime":"0","summary":"证券之星消息,11月21日仟源医药发生大宗交易,交易数据如下:大宗交易成交价格8.54元,相对当日收盘价折价15.19%,成交96.71万股,成交金额825.89万元,买方营业部为国泰海通证券股份有限公司大同向阳街证券营业部,卖方营业部为国泰海通证券股份有限公司大同向阳街证券营业部。近三个月该股共发生3笔大宗交易,合计成交2.42万手,折价成交3笔。截至2025年11月21日收盘,仟源医药报收于10.07元,下跌5.62%,换手率5.15%,成交量11.56万手,成交额1.18亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100028319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","BK0046","300254","BK0114","BK0077","BK0028"],"gpt_icon":0},{"id":"2584491450","title":"11月19日仟源医药现1笔折价17.32%的大宗交易 合计成交902万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584491450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584491450?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:26","pubTimestamp":1763544378,"startTime":"0","endTime":"0","summary":"证券之星消息,11月19日仟源医药发生大宗交易,交易数据如下:大宗交易成交价格9.02元,相对当日收盘价折价17.32%,成交100万股,成交金额902万元,买方营业部为国泰海通证券股份有限公司大同向阳街证券营业部,卖方营业部为国泰海通证券股份有限公司大同向阳街证券营业部。近三个月该股共发生2笔大宗交易,合计成交1.45万手,折价成交2笔。截至2025年11月19日收盘,仟源医药报收于10.91元,下跌3.19%,换手率4.81%,成交量10.79万手,成交额1.18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900027614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300254","BK0239","BK0077","BK0114","BK0028"],"gpt_icon":0},{"id":"2583949302","title":"股市必读:仟源医药(300254)11月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2583949302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583949302?lang=zh_cn&edition=full","pubTime":"2025-11-13 03:36","pubTimestamp":1762976175,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘,仟源医药报收于11.09元,上涨1.74%,换手率4.03%,成交量9.04万手,成交额9982.08万元。董秘最新回复投资者: 公司生产那些流感或者感冒药品?公司有治疗呼吸系统药物盐酸氨溴索分散片和复方甘草片,以及家庭药师品牌感冒用药氨咖黄敏胶囊等,感谢您的关注。当日关注点来自交易信息汇总:11月12日主力资金净流入829.81万元,显示主力对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300004595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300254","BK0239","BK0077","BK0114","BK0028"],"gpt_icon":0},{"id":"2582325731","title":"仟源医药:生产盐酸氨溴索分散片等呼吸系统药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2582325731","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582325731?lang=zh_cn&edition=full","pubTime":"2025-11-12 16:30","pubTimestamp":1762936256,"startTime":"0","endTime":"0","summary":"证券之星消息,仟源医药(300254)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问:公司生产那些流感或者感冒药品?仟源医药回复:投资者,您好!公司有治疗呼吸系统药物盐酸氨溴索分散片和复方甘草片,以及家庭药师品牌感冒用药氨咖黄敏胶囊等,感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200025693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300254","BK0028","BK0114","BK0239","BK0077","BK0042","BK0046"],"gpt_icon":0},{"id":"2579187408","title":"图解仟源医药三季报:第三季度单季净利润同比增长106.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579187408","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579187408?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:04","pubTimestamp":1761764651,"startTime":"0","endTime":"0","summary":"证券之星消息,仟源医药2025年三季报显示,前三季度公司主营收入6.11亿元,同比上升0.44%;归母净利润2232.74万元,同比下降49.43%;扣非净利润1752.7万元,同比下降35.73%;其中2025年第三季度,公司单季度主营收入2.38亿元,同比上升14.82%;单季度归母净利润2194.66万元,同比上升106.06%;单季度扣非净利润2253.87万元,同比上升212.36%;负债率62.76%,投资收益146.94万元,财务费用1752.28万元,毛利率67.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000003039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300254"],"gpt_icon":0},{"id":"2579998909","title":"仟源医药:10月28日高管虞英民减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579998909","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579998909?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:01","pubTimestamp":1761742916,"startTime":"0","endTime":"0","summary":"证券之星消息,根据10月29日市场公开信息、上市公司公告及交易所披露数据整理,仟源医药(300254)最新董监高及相关人员股份变动情况:2025年10月28日公司高管虞英民共减持公司股份1.0万股,占公司总股本为0.0039%。变动期间公司股价上涨3.01%,10月28日当日收盘报11.28元。仟源医药近半年内的董监高及核心技术人员增减持详情如下:仟源医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900042613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","300254","BK0077","BK0114","BK0028","BK0042"],"gpt_icon":0},{"id":"2577936393","title":"仟源医药最新公告:股东翁占国拟减持不超3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2577936393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577936393?lang=zh_cn&edition=full","pubTime":"2025-10-22 18:49","pubTimestamp":1761130184,"startTime":"0","endTime":"0","summary":"仟源医药(300254.SZ)公告称,持股5%以上股东翁占国计划自公告披露之日起15个交易日后的3个月内(即2025年11月13日至2026年2月12日),以集中竞价和大宗交易方式减持公司股份不超过768.31万股(占公司总股本比例不超过3%),减持原因为个人资金需求。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200031432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300254","BK0028","BK0114","BK0046","BK0239","BK0042"],"gpt_icon":0},{"id":"2577351132","title":"10月22日仟源医药现492.3万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2577351132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577351132?lang=zh_cn&edition=full","pubTime":"2025-10-22 16:55","pubTimestamp":1761123334,"startTime":"0","endTime":"0","summary":"证券之星消息,10月22日仟源医药发生大宗交易,交易数据如下:大宗交易成交价格10.94元,相对当日收盘价折价0.55%,成交45万股,成交金额492.3万元,买方营业部为华宝证券股份有限公司合肥潜山路证券营业部,卖方营业部为方正证券股份有限公司上海杨高南路证券营业部。近三个月该股共发生1笔大宗交易,合计成交4500.0手,折价成交1笔。截至2025年10月22日收盘,仟源医药报收于11.0元,上涨0.27%,换手率3.45%,成交量7.74万手,成交额8533.38万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200025928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300254","BK0114","BK0046","BK0028","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773164745480,"stockEarnings":[{"period":"1week","weight":0.0432},{"period":"1month","weight":0.0654},{"period":"3month","weight":0.2173},{"period":"6month","weight":0.1588},{"period":"1year","weight":0.3538},{"period":"ytd","weight":0.2401}],"compareEarnings":[{"period":"1week","weight":0.0001},{"period":"1month","weight":0.0142},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.064},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山西仟源医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24916人(较上一季度增加13.25%)","perCapita":"9067股","listingDate":"2011-08-19","address":"山西省大同市云州区大同经济技术开发区生物科技创新产业园翠微街2号","registeredCapital":"25610万元","survey":" 山西仟源医药集团股份有限公司的主营业务是医药、保健食品的研发、生产、销售及医学诊断、基因保存、孕环境检测。公司的主要产品是磷霉素氨丁三醇散、依巴斯汀片、盐酸坦索罗辛缓释胶囊、酒石酸伐尼克兰片、蒙脱石散、维生素AD滴剂、盐酸氨溴索分散片、盐酸舍曲林片、盐酸氟西汀胶囊、盐酸西那卡塞片、阿哌沙班片、利伐沙班片、精氨酸培哚普利片、保灵牌孕宝口服液、DNA基因保存。","listedPrice":13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仟源医药(300254)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仟源医药(300254)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仟源医药,300254,仟源医药股票,仟源医药股票老虎,仟源医药股票老虎国际,仟源医药行情,仟源医药股票行情,仟源医药股价,仟源医药股市,仟源医药股票价格,仟源医药股票交易,仟源医药股票购买,仟源医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仟源医药(300254)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仟源医药(300254)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}